demand of customer in this period due to economic recession. The Company and its subsidiary companies have announced net losses of THB 133 million in Q2/2017 or increase loss by 9% compared to the period
decreased by 64% compared to the same period at the previous year. The main reason from decrease in service revenue due to Wutiisak Clinicintergroup Co., Ltd. “Wuttisak” changed business to franchise model. 2
168.54 million and Baht 69.08 million, respectively, are due to the payment for construction. Meanwhile, as of December 31, 2017 and December 31, 2018, the Company’s property, plant and equipment were
, a decrease of 4% YoY, mainly due to financial statement adjustment in accordance with new Thai accounting standards and decline in overall fruit juice market. Export branded sales continued to grow
from Baht 475.1 million in 2Q2019 due to a decrease of Other Utilities Revenue by 95.7% YoY and Operating Revenue of Utilities business by 7.9% YoY despite an increase of Solar rooftop project revenue by
, inclusive of CSL’s revenue and equipment rental from partnership with TOT (see significant event). Excluding IC and equipment rental, service revenue would have been +5.7% YoY and +1.6% QoQ, against the FY18
Quarter 2018 was Baht 29.09 million, due to the expenses paid for tools and equipment replacement after their useful life of Baht 20.54 million and cash advance payment for purchase of assets of Baht 8.73
Quarter 2018 was Baht 73.41 million, due to the expenses paid for tools and equipment replacement after their useful life of Baht 67.65 million and cash advance payment for purchase of assets of Baht 5.99
years ending 31 December 2017 and 2018, the Group’s total revenue increased from THB 2,515.2 Mn in 2017 to THB 2,964.7 Mn in 2018, an increase of THB 449.5 Mn or 17.9%. This was mainly due to increased
hospitals and medical equipment that will support continuous growth momentum in demand for medical devices in Thailand. 4 Due to growth medical device business, the Company plans to develop new products as